Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 354

A band-aid on a bullet wound

These are extraordinary times and they have elicited extraordinary measures from government and central banking authorities the world over. The invasive and far-reaching effects of COVID-19 were enough to stop the 11-year bull market in risk markets in its tracks. The difficult question for society and financial markets is when can we expect some normalisation to occur in a post-virus world.

We feel this pandemic has changed consumer behavioural habits for the foreseeable future and will have devastating ramifications for the economy. At the same time, the virus has also exposed some pre-existing shortcomings in the structure of the economy and financial markets.

Full marks to the co-ordinated efforts of our global central bankers and politicians who have all dug deep into their accommodative war chest with eye-watering quantitative easing and fiscal programs. Estimations for balance sheet expansion commitments in recent weeks from the US Federal Reserve (the Fed), the European Central Bank (ECB), the Bank of Japan (BoJ) and Bank of England (BoE) alone amount to more than US$5 trillion, coming off a relatively tiny negative number last year.

For some perspective, that is a multiple of two and a half from prior peak balance sheet expansion periods in late 2009 and 2016. Sprinkle the unprecedented global fiscal measures on top and this has provided the impetus for the recent risk rally from the 35% decline in equities.

We believe this recent rally shows all the signs of historical bear market risk bounces, most recently through the GFC where markets had episodic rallies in the secular downtrend. The bigger picture template is the Japanese model, where equities failed to return highs that were reached more than a decade earlier.

Corporate balance sheets will be severely tested

COVID-19 has accentuated the financial distress on many consumers and corporate balance sheets that fiscal and monetary stress cannot completely alleviate. Unfortunately, a wave of global consumer defaults is just getting started. Even following the ‘flattening of the infection curve’, travel and education will be altered, and shopping and work patterns will be changed forever. The corporate balance sheet which was already bursting from the seams with debt. US non-financial corporate debt is a record 47% of GDP, and it will become even more bloated as cash-starved corporations pile on the debt as their revenues dry up.

We have warned for years about the systemic risk that corporate debt poses to the financial marketplace and to paraphrase the well-worn market anecdote, ‘as this tide goes out, corporate debt will be found to be swimming stark naked.’ Unfortunately, as hopes of a V-shaped economic recovery diminish so do the revenue prospects for corporations particularly those smaller companies that need to borrow to survive.

Downgrading these companies will only add fuel to the fire as many performance-chasing fund managers have stuffed their yield-seeking portfolios with sub-standard debt. Both client redemptions and credit downgrades will force selling at discounted and distressed prices.

A tsunami of corporate bonds due to mature

Another crack in the wall of the corporate debt market is the tsunami of bonds rated BBB or below in the US that are set to mature this year – a staggering $840 billion worth of bonds. The Fed announced recently that it will expand its bond-buying programme to include debt that was investment-grade rated as of 22 March. However, this was later downgraded to no lower than BB-, which is three levels into high yield (once called junk bond).

The Fed's intention to purchase ETFs that track speculative grade debt is an indication of how deep it needs to dig into its monetary policy toolkit to rescue these fallen angels. It is important to remember that Fed buying or supporting asset prices fails to replace cash flows or fortify balance sheets.

This is just a band-aid on a bullet wound.

In the good times, it is always easy to turn a blind eye to flawed practices. Aside from the borrowing bonanza over the decade-long rally in risk, another artificial support for risk markets has been the preponderance of equity buybacks. Studies from Goldman Sachs analysts suggest US companies will spend half as much repurchasing their own stock in 2020 compared to last year. With the expected suspension of dividends, this takes away demand from the equity market that fiscal and monetary stimulus cannot provide.

The shape of the economic recovery will provide lots of discussion points over the journey of the pandemic, with many dispersions on the economic forecasts to be expected. One thing that we can say with certainty is that the economic damage will be unprecedented for the modern era, as the below forecasts for the US second quarter GDP illustrate. We maintain that the risks of re-infection or second wave from the virus along with an elongated containment policy from authorities will only serve to deepen the economic recession and the lagged effect will ultimately push the economy towards a global depression.

Second quarter 2020 US GDP growth forecasts by global investment firms

Source: Bloomberg.

Looking at previous US equity bear market drawdowns (defined as a 20% loss from the highs) since the Great Depression supports the view that there is still room to run on the downside for risk markets. The average fall from top to bottom of these 10 bear market events was 373 trading days, or over a year before we can expect a trough in equity markets.

At a minimum, we expect there will be a retest of the recent stock market bottom, and investors should brace themselves for risk market declines as we anticipate the worst drop in global GDP since World War 2.

Oil price collapse is a warning

The recent carnage in the crude oil market, where West Texas Intermediate crude futures fell more than USD55 to settle at a negative USD37.63, created history. It was the first time it had traded in negative territory and is a clear example of the structural problems currently facing financial markets. This price action in crude embodies how the virus has exposed the frailties of market ecosystems. The lack of demand for oil occurs as global containment keeps the V-8 in the garage and the Boeing 737 in the hangar while on the supply side, shutting down production is difficult and costly. 

Oil is the world’s most important commodity and driver of inflation expectations, yet it has fast lost its value. JCB has long warned about the secular disinflationary forces pervading in the economy. It is a salient reminder that an extended period of falling prices is what differentiates a garden variety recession from an impending depression or the lost decades in Japan.

The disequilibrium in the oil market is expected to persist over 2020 and will cause waves throughout the financial system given its high correlation to all asset classes and its importance on Wall St, Main Street and Capitol Hill. The effects should place further pressure on the commodity currencies and high-yield bond market as well as emerging market countries whose fortunes are entwined with crude. It reinforces our belief in a retest of the March equity lows, given the relationship with the S&P500 as shown in the chart below.

The S&P 500 Total Return Index vs the Price of Crude Oil (USD)

 

The rapid fall in energy prices is also another shot across the bow for bond naysayers clinging on to the inflation argument in their crusade against the allocation to high-grade bonds in a well-constructed portfolio.

 

Chris Manuell CMT is a Portfolio Manager at Jamieson Coote Bonds (JCB). This article contains general information only and does not consider the circumstances of any investor.

JCB is an investment manager partner of Channel Capital, a sponsor of Firstlinks. For more articles and papers from Channel Capital and partners, click here.

 

RELATED ARTICLES

The ASX's 16-year drought: a rebuttal

How likely are market crashes?

Crisis, contagion or QE? The bigger picture

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

AFIC on its record discount, passive investing and pricey stocks

A triple headwind has seen Australia's biggest LIC swing to a 10% discount and scuppered its relative performance. Management was bullish in an interview with Firstlinks, but is the discount ever likely to close?

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.